AIM ImmunoTech, Inc. (AIM)
0.531
+0.01
(+1.34%)
USD |
NYAM |
Apr 13, 16:00
0.5195
-0.01
(-2.17%)
After-Hours: 06:04
AIM ImmunoTech Cash from Investing (TTM) : 1.853M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Agenus, Inc. | 1.194M |
| Curis, Inc. | 2.50M |
| Plus Therapeutics, Inc. | -0.854M |
| Windtree Therapeutics, Inc. | -5.972M |
| Halozyme Therapeutics, Inc. | -545.81M |